CFTR and cystic fibrosis: This is the case for mutations that affect the kinetics or thermodynamics of CFTR folding in the ER, such as the most frequent CF mutation ΔF508, and which are recognized by ER quality control systems and targeted for degradation (Riordan, 2008).